Wells Fargo Initiates Coverage On Beta Bionics with Overweight Rating, Announces Price Target of $28
Benzinga Newsdesk 1 month ago
Analyst RatingsNewsInitiationPrice Target
Wells Fargo analyst Larry Biegelsen initiates coverage on Beta Bionics (NASDAQ:BBNX) with a Overweight rating and announces Price Target of $28.
Wells Fargo analyst Larry Biegelsen initiates coverage on Beta Bionics (NASDAQ:BBNX) with a Overweight rating and announces Price Target of $28.